Trial Parameters
Condition Atrial Fibrillation
Sponsor CardioFocus
Study Type INTERVENTIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2017-06-16
Completion 2026-10
Interventions
HeartLightAblation
Brief Summary
This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * planned for catheter ablation due to symptomatic paroxysmal atrial fibrillation * failure of at least one anti-arrhythmic drug * others Exclusion Criteria: * overall good health as established by multiple criteria
Related Trials
NCT07118046
Comparison of Fluoroscopy-only vs. Electroanatomic Mapping Strategies for Pulmonary Vein Isolation W
View Trial →
NCT05009797
PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation
View Trial →
NCT04776759
Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry
View Trial →